Arcus Biosciences Statistics
Total Valuation
RCUS has a market cap or net worth of $2.63 billion. The enterprise value is $1.87 billion.
Important Dates
The next estimated earnings date is Tuesday, May 5, 2026, after market close.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RCUS has 125.35 million shares outstanding. The number of shares has increased by 19.20% in one year.
| Current Share Class | 125.35M |
| Shares Outstanding | 125.35M |
| Shares Change (YoY) | +19.20% |
| Shares Change (QoQ) | +11.27% |
| Owned by Insiders (%) | 3.57% |
| Owned by Institutions (%) | 72.91% |
| Float | 88.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.76 |
| Forward PS | 29.10 |
| PB Ratio | 4.21 |
| P/TBV Ratio | 4.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.56 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.36, with a Debt / Equity ratio of 0.35.
| Current Ratio | 4.36 |
| Quick Ratio | 4.32 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -48.25 |
Financial Efficiency
Return on equity (ROE) is -63.26% and return on invested capital (ROIC) is -31.85%.
| Return on Equity (ROE) | -63.26% |
| Return on Assets (ROA) | -21.08% |
| Return on Invested Capital (ROIC) | -31.85% |
| Return on Capital Employed (ROCE) | -42.51% |
| Weighted Average Cost of Capital (WACC) | 8.80% |
| Revenue Per Employee | $410,982 |
| Profits Per Employee | -$587,354 |
| Employee Count | 601 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +153.63% in the last 52 weeks. The beta is 0.92, so RCUS's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | +153.63% |
| 50-Day Moving Average | 21.50 |
| 200-Day Moving Average | 16.80 |
| Relative Strength Index (RSI) | 45.74 |
| Average Volume (20 Days) | 1,269,185 |
Short Selling Information
The latest short interest is 8.61 million, so 6.87% of the outstanding shares have been sold short.
| Short Interest | 8.61M |
| Short Previous Month | 9.01M |
| Short % of Shares Out | 6.87% |
| Short % of Float | 9.71% |
| Short Ratio (days to cover) | 6.50 |
Income Statement
In the last 12 months, RCUS had revenue of $247.00 million and -$353.00 million in losses. Loss per share was -$3.29.
| Revenue | 247.00M |
| Gross Profit | -276.00M |
| Operating Income | -386.00M |
| Pretax Income | -353.00M |
| Net Income | -353.00M |
| EBITDA | -376.00M |
| EBIT | -386.00M |
| Loss Per Share | -$3.29 |
Full Income StatementBalance Sheet
The company has $981.00 million in cash and $219.00 million in debt, with a net cash position of $791.00 million or $6.31 per share.
| Cash & Cash Equivalents | 981.00M |
| Total Debt | 219.00M |
| Net Cash | 791.00M |
| Net Cash Per Share | $6.31 |
| Equity (Book Value) | 631.00M |
| Book Value Per Share | 5.04 |
| Working Capital | 776.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$482.00 million and capital expenditures -$2.00 million, giving a free cash flow of -$484.00 million.
| Operating Cash Flow | -482.00M |
| Capital Expenditures | -2.00M |
| Depreciation & Amortization | 10.00M |
| Net Borrowing | 49.00M |
| Free Cash Flow | -484.00M |
| FCF Per Share | -$3.86 |
Full Cash Flow StatementMargins
Gross margin is -111.74%, with operating and profit margins of -156.28% and -142.91%.
| Gross Margin | -111.74% |
| Operating Margin | -156.28% |
| Pretax Margin | -142.91% |
| Profit Margin | -142.91% |
| EBITDA Margin | -152.23% |
| EBIT Margin | -156.28% |
| FCF Margin | n/a |
Dividends & Yields
RCUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.20% |
| Shareholder Yield | -19.20% |
| Earnings Yield | -13.28% |
| FCF Yield | -18.20% |
Analyst Forecast
The average price target for RCUS is $29.20, which is 39.05% higher than the current price. The consensus rating is "Buy".
| Price Target | $29.20 |
| Price Target Difference | 39.05% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 32.15% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RCUS has an Altman Z-Score of -0.26. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.26 |
| Piotroski F-Score | n/a |
